4.7 Review

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

Journal

NATURE REVIEWS CANCER
Volume 16, Issue 11, Pages 680-693

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc.2016.85

Keywords

-

Categories

Funding

  1. American Cancer Society [PF-15-096-01-TBE]
  2. US National Institutes of Health (NIH) [T32 GM007753]
  3. Burroughs Wellcome Fund, the Ludwig Center at the Massachusetts Institute of Technology (MIT)
  4. NIH [P30CA1405141, GG006413, R01CA168653]

Ask authors/readers for more resources

Altered cell metabolism is a characteristic feature of many cancers. Aside from well-described changes in nutrient consumption and waste excretion, altered cancer cell metabolism also results in changes to intracellular metabolite concentrations. Increased levels of metabolites that result directly from genetic mutations and cancer-associated modifications in protein expression can promote cancer initiation and progression. Changes in the levels of specific metabolites, such as 2-hydroxyglutarate, fumarate, succinate, aspartate and reactive oxygen species, can result in altered cell signalling, enzyme activity and/or metabolic flux. In this Review, we discuss the mechanisms that lead to changes in metabolite concentrations in cancer cells, the consequences of these changes for the cells and how they might be exploited to improve cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available